Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Puzzling Study Links Antibiotic Use to Breast Cancer

By HospiMedica staff writers
Posted on 24 Feb 2004
A large study has shown that women who take antibiotics have an increased risk of breast cancer. More...
The study was published in the February 16th issue of the Journal of the American Medical Association (JAMA).

Researchers used computerized pharmacy and breast cancer screening databases to compare antibiotic use of 2,266 women with breast cancer to similar information from 7,953 women without breast cancer. All were age 20 and over, and a wide variety of frequently prescribed antibiotics was examined. The results showed that the more antibiotics women took, the higher their risk of breast cancer. Women who took antibiotics for more than 500 days or had more than 25 prescriptions over an average period of 17 years had more than twice the risk of breast cancer as women who had not taken any antibiotics.

The researchers point out that the study does not mean that antibiotics cause breast cancer but only shows an association between the two. Similar results were found in a Finnish study of almost 10,000 women. More studies are required to examine whether specific indications for antibiotic use or times of use would affect the outcome. The authors say that antibiotics can affect bacteria in the intestine and affect how certain foods are broken down that may prevent cancer. Another hypothesis is that the effects of antibiotics on the body's immune response and response to inflammation could be related to the development of cancer. Still another is that underlying conditions leading to the need for antibiotics caused the increased risk, or that a weakened immune system is the cause of the association.

"This trial suggests another piece in the puzzle of factors that may potentially be involved in the development of breast cancer,” said Andrew C. von Eschenbach, M.D., director of the U.S. National Cancer Institute (NCI, Bethesda, MD, USA) and one of the authors. The other authors were from the Group Health Cooperative (GHC), the University of Washington, and the Fred Hutchinson Cancer Center, all in Seattle (WA, USA).


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.